JCR Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 5/6
JCR Pharmaceuticals has a total shareholder equity of ¥56.5B and total debt of ¥23.3B, which brings its debt-to-equity ratio to 41.3%. Its total assets and total liabilities are ¥102.2B and ¥45.8B respectively. JCR Pharmaceuticals's EBIT is ¥7.5B making its interest coverage ratio -147.7. It has cash and short-term investments of ¥18.8B.
Key information
41.3%
Debt to equity ratio
JP¥23.30b
Debt
Interest coverage ratio | -147.7x |
Cash | JP¥18.76b |
Equity | JP¥56.47b |
Total liabilities | JP¥45.75b |
Total assets | JP¥102.23b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: JCRR.F's short term assets (¥57.6B) exceed its short term liabilities (¥30.1B).
Long Term Liabilities: JCRR.F's short term assets (¥57.6B) exceed its long term liabilities (¥15.6B).
Debt to Equity History and Analysis
Debt Level: JCRR.F's net debt to equity ratio (8%) is considered satisfactory.
Reducing Debt: JCRR.F's debt to equity ratio has increased from 17.8% to 41.3% over the past 5 years.
Debt Coverage: JCRR.F's debt is well covered by operating cash flow (40%).
Interest Coverage: JCRR.F earns more interest than it pays, so coverage of interest payments is not a concern.